(S)-N-(5-(4-(1-(Benzo[D][1,3]Dioxol-5-Yl)Ethyl)Piperazin-1-Yl)-1,3,4-Thiadiazol-2-Yl)Acetamide, Hydrochloride Salt

1 trials NNeurology/Psychiatry Orphan designation

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

7 Countries

Phase II

Phase II: 1

Indications tested

Progressive supranuclear palsy 1

Sponsors using this IMP

Ferrer Internacional S.A. 1

All trials

1 total

PROSPER: clinical Phase 2 study to test how safe and effective is a new medicine called FNP-223 to slow disease progression of progressive s… Ended

2023-510366-28-00 Phase II 7 countries Ferrer Internacional S.A.

Showing 1–1 of 1 trials

← All drugs A–Z